On December 20, 2023, Kevin Kotler resigned as a member of the board of directors of Heron Therapeutics, Inc., effective December 31, 2023. Mr. Kotler?s decision to resign was not the result of any disagreements with the Company relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.55 USD | +8.97% | 0.00% | +50.00% |
Apr. 23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
Mar. 21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.00% | 352M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Kevin Kotler Resigns as A Member of the Board of Directors of Heron Therapeutics, Inc., Effective December 31, 2023